Mirae Asset Global Investments
AKRO

Mirae Asset Global Investments’s Akero Therapeutics AKRO Stock Holding History

Mirae Asset Global Investments’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,092
Closed -$147K – 1646
2025
Q3 		$147K Buy
3,092
+13
+0.4% +$629 ﹤0.01% 1159
2025
Q2 		$164K Buy
3,079
+415
+16% +$18.9K ﹤0.01% 1071
2025
Q1 		$114K Buy
2,664
+338
+15% +$14.3K ﹤0.01% 1110
2024
Q4 		$65.7K Sell
2,326
-185
-7% -$5.6K ﹤0.01% 1223
2024
Q3 		$70.9K Buy
2,511
+446
+22% +$11.6K ﹤0.01% 1241
2024
Q2 		$48.3K Sell
2,065
-23,593
-92% -$505K ﹤0.01% 1257
2024
Q1 		$845K Sell
25,658
-14,227
-36% -$342K ﹤0.01% 1627
2023
Q4 		$931K Buy
39,885
+9,567
+32% +$189K ﹤0.01% 1659
2023
Q3 		$1.53M Buy
30,318
+3,499
+13% +$163K ﹤0.01% 1301
2023
Q2 		$1.24M Buy
26,819
+4,332
+19% +$199K ﹤0.01% 1444
2023
Q1 		$860K Buy
22,487
+6,203
+38% +$277K ﹤0.01% 1621
2022
Q4 		$892K Buy
16,284
+3,307
+25% +$142K ﹤0.01% 1560
2022
Q3 		$442K Buy
+12,977
New +$199K ﹤0.01% 1946

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global Investments's AKRO Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 3,092 shares — an estimated $147K sold.

Mirae Asset Global Investments first reported a position in AKRO in Q3 2022 and held it in 13 quarters. The position peaked at $1.53M in Q3 2023. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 3,092 Akero Therapeutics shares in Q4 2025, an estimated $147K.
  • Mirae Asset Global Investments first reported a position in Akero Therapeutics in Q3 2022 and held it in 13 quarters.
  • Mirae Asset Global Investments's Akero Therapeutics position peaked at $1.53M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.